Live Breaking News & Updates on Pharmaleads Greater

IACTA Pharmaceuticals and Pharmaleads to Develop the World s First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain
News provided by
Share this article
-
License agreement aims to accelerate global development of DENKIs, leveraging expertise and resources of both companies
IRVINE, Calif., PARIS, HONG KONG, Jan. 7, 2021 /PRNewswire/  IACTA Pharmaceuticals, Inc. ( IACTA ) and Pharmaleads, with Pharmaleads Greater China, today announced they have entered into licensing agreements, with IACTA acquiring global rights to Pharmaleads Dual Enkephalinase Inhibitors (DENKI
®), a novel class of non-opioid compounds for the treatment of acute and chronic ocular pain. ....

France General , Marjan Farid , Damon Burrows , Tanja Ouimet , Taryn Conway , Allergan Inc , Zhaoke Hong Kong Ophthalmology Pharmaceutical Limited , Gavin Herbert Eye Institute , Pharmaceuticals Inc , Pharmaleads Greater China , Pharmaleads Greater , Associate Vice President , Strategic Advisor , Marjan Farid Director , Refractive Surgery , Vice Chair , Ophthalmic Faculty , Gavin Herbert Eye , Hong Kong , Ophthalmology Pharmaceutical Limited , Private Securities Litigation Reform Act , பிரான்ஸ் ஜநரல் , மார்ஜன் பாரித் , டாமன் பர்ரோஸ் , ட்யாஂஜா ஒஉய்மெத் , தரய்ன் கான்வே ,